UBTF Tandem Duplications in Pediatric MDS and AML: Implications for Clinical Screening and Diagnosis
Barajas, J. M.; Umeda, M.; Contreras, L.; Khanlari, M.; Westover, T.; Walsh, M. P.; Xiong, E.; Yang, C.; Otero, B.; Arribas-Layton, M.; Abdelhamed, S.; Song, G.; Ma, X.; Thomas, M. E.; Ma, J.; Klco, J. M.
Show abstract
Recent genomic studies in adult and pediatric acute myeloid leukemia (AML) demonstrated recurrent in-frame tandem duplications (TD) in exon 13 of upstream binding transcription factor (UBTF). These alterations, which account for ~4.3% of AMLs in childhood and up to 3% in adult AMLs under 60, are subtype-defining and associated with poor outcomes. Here, we provide a comprehensive investigation into the clinicopathological features of UBTF-TD myeloid neoplasms in childhood, including 89 unique pediatric AML and 6 myelodysplastic syndrome (MDS) cases harboring a tandem duplication in exon 13 of UBTF. We demonstrate that UBTF-TD myeloid tumors are associated with dysplastic features, low bone marrow blast infiltration, and low white blood cell count. Furthermore, using bulk and single-cell analyses, we confirm that UBTF-TD is an early and clonal event associated with a distinct transcriptional profile, whereas the acquisition of FLT3 or WT1 mutations is associated with more stem cell-like programs. Lastly, we report rare duplications within exon 9 of UBTF that phenocopy exon 13 duplications, expanding the spectrum of UBTF alterations in pediatric myeloid tumors. Collectively, we comprehensively characterize pediatric AML and MDS with UBTF-TD and highlight key clinical and pathologic features that distinguish this new entity from other molecular subtypes of AML. Key PointsO_LILargest cohort of pediatric UBTF-TD in myeloid neoplasms reported to date. C_LIO_LIUse of single-cell DNA+protein sequencing technology in 3 UBTF-TD samples reveals a clonal evaluation pattern characterized by sequential acquisition of WT1 and FLT3 mutations and a more stem cell-like protein expression pattern. C_LIO_LIPediatric MDS and AML patients with UBTF-TD alterations dysplastic features with an increase erythroid precursors. C_LIO_LITandem duplications in exon 9 of UBTF represent a rare but functionally equivalent subgroup of UBTF-TD myeloid neoplasms. C_LI Impact StatementUBTF tandem duplications (TD) are subtype-defining genomic alterations in adult and pediatric myeloid neoplasms. Here, we provide a comprehensive characterization of the largest cohort of pediatric UBTF-TD cases to date, including the recognition of additional UBTF alterations that mimic the exon 13 duplications in pediatric AML.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- CXCL8 secreted by immature granulocytes inhibits wildtype hematopoiesis in chronic myelomonocytic leukemia 96%
- Germline RUNX1 Variation and Predisposition to Childhood Acute Lymphoblastic Leukemia 96%
- Expansion, persistence and efficacy of donor memory-like NK cells for the treatment of post-transplant relapse 95%
Similar papers in this journal
- Loss of erythroblasts in acute myeloid leukemia causes iron redistribution with clinical implications 97%
- Monosomy 7/del(7q) Cause Sensitivity to Inhibitors of Nicotinamide Phosphoribosyltransferase in Acute Myeloid Leukemia 96%
- Acute myeloid leukemia stratifies as two clinically relevant sphingolipidomic subtypes 94%
Similar papers in this journal
- DEK::NUP214 acts as an XPO1-dependent transcriptional activator of essential leukemia genes 97%
- A transcriptomic continuum of differentiation arrest identifies myeloid interface acute leukemias with poor prognosis 97%
- The Splicing Factor PTBP1 interacts with RUNX1 and is Required for Leukemia Cell Survival 96%
Similar papers in this journal
- BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor 97%
- Clinicopathologic Correlates and Natural History of Atypical Chronic Myeloid Leukemia 96%
- A JAK/STAT-Mediated Inflammatory Signaling Cascade Drives Oncogenesis In AF10-Rearranged AML 96%
Similar papers in this journal
- Quantification of measurable residual disease using duplex sequencing in adults with acute myeloid leukemia 95%
- Inducing synthetic lethality for selective targeting of acute myeloid leukemia cells harboring STAG2 mutations 95%
- Subtype-specific and co-occurring genetic alterations in B-cell non-Hodgkin lymphoma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.